Mortality Rates and Comorbidities Associated With Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis

Opinion
Video

Anna Podolanczuk, M.D., M.S., discusses how the mortality rates for patients with idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF) are impacted by comorbidities, including the role of autoimmune diseases in the pathophysiology of these conditions.

Video content above is prompted by the following:

  1. What are the mortality rates for patients with IPF and PPF?
  2. What are the comorbidities associated with IPF and PPF? How do autoimmune diseases contribute to the pathophysiology?

Newsletter

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Recent Videos
2 experts are featured in this series.
1 expert is featured in this series.
1 expert in this video
1 expert in this video
1 expert in this video
2 experts are featured in this series.
1 expert is featured in this series.
1 expert in this video
1 expert in this video
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.